Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway

Journal of Biological Chemistry(2024)10.1016/j.jbc.2024.105680Source: DataRank Database

Short peptides based on the conserved regions of MIEN1 protein exhibit anticancer activity by targeting the MIEN1 signaling pathway is a research paper published in Journal of Biological Chemistry (2024). On theSindex it has a DataRank of 0.364. It has been cited 8 times, with 4 citing works in its 1-hop citation network.

N/A

0.364DataRank · unranked

Scored on demand from live citation data

Open Access8 citations · 4 citing works in its network

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (22)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 91%Citation Network 9%

Base Score Contribution

0.330

From this paper's citation signal

Citation Network Contribution

0.0340

From 3 citing papers with measurable signal

Learn more about DataRank methodology →

Top 4 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 4 citers.

EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics
International Journal of Molecular Sciences202414 citations164 referencesContributes 0.017
Innovations in Metal-Based Nanomedicines to Interfere with the Signaling Communications of Prostate Cancer
BioNanoScience20244 citations117 referencesContributes 0.014
Peptide inhibitors: Breaking cancer code
European Journal of Medicinal Chemistry202512 citations263 referencesContributes 0.010
Targeting Tumor Dormancy and Recurrence: Molecular Mechanisms and Peptide Therapeutic Delivery
MedComm – Oncology20260 citations494 referencesContributes 0.000

Authors (11)

Priyanka P. Desai ORCID,Antariksh Tyagi ORCID,Jana B. Lampe,Yogesh Srivastava ORCID,Michael Donkor ORCID

Live enrichment

PubMed:38272230 PMC:PMC10878790

National Institutes of Health

Grant: R01CA220273

National Institutes of Health

Grant: S21MD012472

National Institutes of Health

Grant: U54MD006882

Summerfield G Roberts Foundation

goldLicense: cc-by

publisherhttp://www.jbc.org/article/S0021925824000565/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925824000565?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925824000565?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10878790/pdf/main.pdf

Europe_PMChttps://europepmc.org/articles/PMC10878790

MeSH Terms

Cell LineAnimalsHumansMiceNeoplasmsIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsMolecular ChaperonesNeoplasm ProteinsSignal TransductionCell ProliferationCell MovementEpithelial-Mesenchymal TransitionMolecular Docking Simulation

Keywords

PharmacokineticsPeptide designProtein MOTIFEpidermal growth factor (EGF)Breast cancerCancer BiologyAnticancer PeptidesEpithelial-mesenchymal Transition (Emt)